Collagen metabolism ameliorant and its use
AssigneeKanebo, Ltd.
InventorsMasanori Nakata, Shintaro Inoue, Mikio Sotomura, Junsei Taira, Itaru Miyamoto
Life of this patent
Estimating the term…
Abstract
This invention relates to a collagen metabolism ameliorant containing N-methyl-L-serine as an active ingredient, more particularly, a collagen metabolism ameliorant efficacious against collagen hypometabolism caused by aging or diseases accompanied with an abnormal cumulation of collagen, such as hepatic and pulmonary fibroses, keloid, hypertrophic scar, scleroderma, fibrosis in the scalp, or the like.
Claims5
A method of ameliorating collagen metabolism in a human patient, said method comprising the step of administering N-methyl-L-serine in a dosage between 0.1 and 1,000 mg to said patient.
A method of treating a disease associated with an abnormal accumulation of collagen, said method comprising the step of administering N-methyl-L-serine in a dosage between 0.1 and 1,000 mg to a patient afflicted with said disease.
Dependencies are inferred from the claim text.